Viewing nowCombinationRosatol Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanpung Pharmaceutical Co., Ltd.

MFDS item code 201904374 · Approved 2019.06.26
Treatment of hypertension not controlled with monotherapy
Used for hypertension that is not adequately controlled with monotherapy.
○ Adults The usual dose of this drug is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg daily are not recommended. The maximum antihypertensive effect generally occurs approximately 3 weeks after starting treatment. This drug may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start treatment with this drug when the expected effect has not been achieved with monotherapy. 1. Replacement therapy: Combination therapy with individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this drug. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows the hydrochlorothiazide dose to be reduced without reducing the overall antihypertensive effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg; if blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose if creatinine clearance is 30 mL/min or greater. Use of this drug is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Use of this drug is not recommended in these patients because the initial losartan potassium dose of 25 mg required for patients with hepatic impairment who need dose adjustment cannot be administered with this combination.
Pediatric patients (under 18 years): There is no experience with use in children and adolescents; therefore, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm to the fetus if taken during pregnancy, especially during the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. This medication should not be administered to certain patients, for instance, those allergic to this medication or its components, patients with severely impaired kidney function, severe liver impairment, women who are pregnant or may become pregnant, and those with specific electrolyte abnormalities. Additionally, patients with low blood pressure or problems with renal blood vessels, those with a history of liver disease, diabetes or gout, and the elderly should use this medication with caution, and sun exposure should be limited due to an increased risk of skin cancer, while skin condition should be monitored frequently. During the use of this medication, electrolyte imbalances, especially changes in potassium levels, should be carefully monitored, as symptoms of excessively low blood pressure, dizziness, or drowsiness may occur, requiring caution while driving or operating machinery. As this medication may interact with other drugs, especially potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs, and lithium preparations, consultation with a physician is advised if taken in combination. This medication also requires caution in nursing women, and it is necessary to decide whether to discontinue breastfeeding or consult a doctor prior to administration. The safety of this medication in children and adolescents has not been established, thus it is not administered to this age group. If any abnormal symptoms appear during administration, consult a healthcare professional immediately, especially in cases of suspected allergic reactions such as skin rash, difficulty breathing, or severe dizziness; discontinue use immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light, and the storage temperature should be maintained between 1 degrees and 30 degrees Celsius at room temperature. By storing it this way, the efficacy of the medication can be safely maintained.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Hanpung Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.